Digital health companies' plans focused on managing the impact of GLP-1 drugs, which have placed enormous pressure on health ...

The investing pros at Firetrail forecast another strong year for ResMed shares in 2025. The post ResMed shares are up 42% in ...

Adults with type 2 diabetes using a GLP-1 receptor agonist have a similar risk for developing thyroid cancer as those using a ...

You’ve likely heard the term GLP1 when it comes to medications. These are the diabetes treatments now being used as a tool for weight loss. While the results can be dramatic, many are wondering if ...

Scientists have found a way to help the body make more of an Ozempic-like fullness hormone to cut cravings and improve health.

A study has found no evidence that glucagon-like peptide 1 receptor agonist (GLP1-RA) use is associated with an increased ...

McDonald's shares underperformed in 2024, likely due to the rise of GLP-1 medications. Learn why MCD stock is a Sell.

Industry leaders can use Circana's data to develop personalized products and services targeting users of GLP-1 agonist medications..

One in eight people living in the United States has taken a GLP-1 medication — such as Ozempic, Mounjaro, or Zepbound — for ...

At 53, she's not only lost over 50 pounds but has successfully maintained her weight loss for over a year. Here's her ...

Consumers who take GLP-1 drugs might switch what they eat, but they largely spend the same amount of money on CPG food and ...

As GLP-1 RA use soars, experts are worried that patients may not be getting the right nutrients in their diets. How can ...